¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò : 2024-06-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò : 2024-06-28
±³À°ÀÏÀÚ : 2024-06-28
±³À°Àå¼Ò : ¾Ú¹ö¼­´õ ¼­¿ï Ç®¸¸ È£ÅÚ ±×·£µåº¼·ë 2Ãþ

±³À°ÁÖÁ¦ : 2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ

´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674

À̸ÞÀÏ : gschoi@humming.co.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 20,000¿ø  

ºñ°í ȸ¿ø 2¸¸¿øºñȸ¿ø 30¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 28ÀÏ 17:10~17:40 (±³À°°­¿¬)Current and emerging topicals and complementary therapies ±èÁöÈñ(¿¬¼¼´ëÇб³ ¿ëÀμ¼ºê¶õ½º ÇǺΰú)

±³À°½Ã°£ 06¿ù 28ÀÏ 17:40~18:10 (±³À°°­¿¬)Practical pearls of systemic immunomodulators ¹Ú±Í¿µ(Á߾Ӵ뺴¿ø ÇǺΰú)

Åä·Ð 06¿ù 28ÀÏ 18:10~18:20 ÁúÀÇÀÀ´ä ()

½Ä»ç 06¿ù 28ÀÏ 18:20~19:00 ½Ä»ç ()

±³À°½Ã°£ 06¿ù 28ÀÏ 19:00~19:30 (±³À°°­¿¬)Optimal use of biologics ¹Úâ¿í(¿¬¼¼´ëÇб³ ½ÅÃ̼¼ºê¶õ½º ÇǺΰú)

±³À°½Ã°£ 06¿ù 28ÀÏ 19:30~20:00 (±³À°°­¿¬)Optimal use of JAK inhibitors Àå¿ëÇö(°æºÏ´ëº´¿ø ÇǺΰú)

Åä·Ð 06¿ù 28ÀÏ 20:00~20:10 ÁúÀÇÀÀ´ä ()

ÈÞ½Ä 06¿ù 28ÀÏ 20:10~20:20 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 28ÀÏ 20:20~20:50 (±³À°°­¿¬)Targeted therapies for type 2 inflammatory diseases ÀÌÁöÇö(¼­¿ï¼º¸ðº´¿ø ÇǺΰú)

±³À°½Ã°£ 06¿ù 28ÀÏ 20:50~21:20 (±³À°°­¿¬)Disease modification in atopic disorders ÀüÁöÇö(°í·Á´ëÇб³ ±¸·Îº´¿ø ÇǺΰú)

Åä·Ð 06¿ù 28ÀÏ 21:20~21:30 ÁúÀÇÀÀ´ä ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò : 2024-06-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 2 : 2024-06-28
´ÙÀ½±Û 2024³â Á¦ 2ȸ ÆÄÁֽà ÀÇ»çȸ ÃÑȸ ¹× ¿¬¼ö±³À° : 2024-06-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
647 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-09 0 543 2018-08-29
646 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-08 0 564 2018-08-29
645 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-07 0 787 2018-08-29
644 ¼­¿ï ¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø ´ëÇÑ°üÀý°æÇÐȸ Á¦9ȸ ¿¬¼ö°­Á : 2018-10-07 0 563 2018-08-29
643 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦ 18ȸ ºÎÀÎ¾Ï ½ÉÆ÷Áö¿ò : 2018-10-07 0 597 2018-08-29
642 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ÇÇÇмº ÀΰÝÀå¾Ö, ¿ì¿ï¼º ÀΰÝÀå¾Ö : 2018-10-06 0 1,070 2018-08-29
641 Àü³² 2018³â Á¦2Â÷ ÀÇ¿ø ¹× º´¿ø±Þ ÀÇ·á±â°ü ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° "ÀÇ»çÇùȸ ¹× °£È£Çùȸ ÀÎÁõ" : 2018-10-06 0 876 2018-08-29
640 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-06 0 433 2018-08-29
639 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hybrid Aortic Live Symposium : 2018-10-06 0 710 2018-08-29
638 °æ±â 2018 ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ½Å°æ°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-06 0 627 2018-08-29
637 ¼­¿ï 2018 Ç¥ÀûÄ¡·á¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2018-10-06 0 513 2018-08-29
636 ¼­¿ï Á¦38Â÷ ´ëÇÑ°üÀý°æÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-06 0 497 2018-08-29
635 °æ³² »ï¼ºÃ¢¿øº´¿ø 2018³â ¼º±Õ°ü´ëÇб³ SMC Changwon ½Å°æ¿Ü°úÇÐ ¿¬¼ö°­Á : 2018-10-06 0 986 2018-08-29
634 ÀÎõ 2018³â ÀÎÇϴ뺴¿ø ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-06 0 787 2018-08-29
633 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦11ȸ ¾Æ»ê±¹Á¦¼ÒÈ­±âº´½ÉÆ÷Áö¾ö(AIDDS) 2018 : 2018-10-06 0 579 2018-08-29
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷